EyePoint, Inc. Payments to Acquire Available-for-sale Securities
EyePoint, Inc. (EYPT) reported Payments to Acquire Available-for-sale Securities of $0 for the 6-month period ending 2018-12-31, per its 10-KT filed 2019-03-18.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2020-03-16
- EyePoint, Inc. payments to acquire available-for-sale securities for the quarter ending 2018-06-30 was $0.00.
- EyePoint, Inc. payments to acquire available-for-sale securities for the quarter ending 2018-03-31 was $0.00.
- EyePoint, Inc. payments to acquire available-for-sale securities for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. payments to acquire available-for-sale securities for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. payments to acquire available-for-sale securities for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- EyePoint, Inc. payments to acquire available-for-sale securities for fiscal 2017 was $5.05M, a 71.16% decline from fiscal 2016.
- EyePoint, Inc. payments to acquire available-for-sale securities for fiscal 2016 was $17.52M, a 71.37% increase from fiscal 2015.
- EyePoint, Inc. payments to acquire available-for-sale securities for fiscal 2015 was $10.22M.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-KT · filed 2019-03-18 | |||
| 2018-06-30 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $0.00 derived: sum of 3 quarters · filed 2019-03-18 | $0.00 10-KT · filed 2019-03-18 |
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10 | $0.00 derived: sum of 2 quarters · filed 2018-05-10 | $0.00 10-Q · filed 2018-05-10 | $0.00 derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $0.00 10-Q · filed 2018-02-08 | $0.00 derived: sum of 3 quarters · filed 2020-03-16 | -$1.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2020-03-16 | -$1.00K derived: sum of 3 quarters · filed 2020-03-16 | $3.00M derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$1.00K derived: sum of 2 quarters · filed 2020-03-16 | $3.00M derived: sum of 3 quarters · filed 2020-03-16 | $5.05M 10-K · filed 2020-03-16 |
| 2017-03-31 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10 | $3.00M derived: sum of 2 quarters · filed 2018-05-10 | $5.05M 10-Q · filed 2018-05-10 | |
| 2016-12-31 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $5.05M 10-Q · filed 2018-02-08 | ||
| 2016-09-30 | $2.05M 10-Q · filed 2017-11-08 | |||
| 2016-06-30 | $17.52M 10-KT · filed 2019-03-18 | |||
| 2015-06-30 | $10.22M 10-K · filed 2017-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |